The global cell-free protein synthesis (CFPS) market is expected to reach USD 585.3 million by 2034, growing at a CAGR of 7.0% from 2025 to 2034. The market is driven by the growing demand for specially formulated proteins, accelerating drug discovery and development, and advances in CFPS technology. However, the market faces challenges such as protein folding complexity, limited industrial production scale, and variability in protein yield and quality. The North American market is expected to grow with the highest CAGR during the forecast period, driven by the demand for therapeutic proteins. The market is segmented by products, applications, end-use, and region. Key players in the market include Thermo Fisher Scientific, Inc., Takara Bio Company, Merck KGaA, and New England Biolabs. The CFPS market has opportunities for growth in therapeutic protein production, point-of-care protein synthesis, and customized protein engineering.
Current Developments in the Cell-Free Protein Synthesis Market: A Focus on Enzymatic Trends
